liveBook · Manning

Binding site

As explained in Build AI Drug Discovery Pipelines

A binding site is the region of a protein or other biomolecule where a ligand or compound interacts.

A binding site is a specific region of a protein or other biomolecule where a ligand can interact and bind. In proteins, nearby residues create a complementary environment of shape, charge, hydrophobicity, and hydrogen-bonding potential, enabling selective molecular recognition. section 9.1.1

Binding sites matter because they provide the structural context for:

  • Molecular docking, which explores ligand orientations and conformations inside active or allosteric sites. section 9.1.1
  • Fragment screening, where small fragments probe more of a target structure and its potential sites than larger compounds. section 7.3.1
  • Lead design, including fragment growing, fragment linking across different sub-pockets, and fragment merging. section 7.3.1

From site to candidate

A docking workflow places a ligand in a protein binding site, generates possible poses, and scores them for complementarity, affinity, and interaction stability. A strong score remains an estimate rather than measured binding free energy, so poses should be compared with crystallographic structures, rescored or briefly simulated, and ultimately validated experimentally. section 9.1.1

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Defines site complementarity and connects it to docking, fragment strategies, scoring limitations, and experimental validation.
Examples
Uses fragment libraries, ligand poses, protein sub-pockets, crystallographic poses, rescoring, molecular dynamics, and experimental validation.
What it assumes
Assumes basic familiarity with proteins and ligands while defining binding-site properties and docking before applying them.
What you can do after
Evaluate ligand binding hypotheses using docking poses, fragment coverage, scoring estimates, structural controls, and experimental confirmation.
How it connects
Connects protein structure, ligands, molecular docking, active sites, allosteric sites, fragment-based drug discovery, and scoring functions.

Related concepts

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.